- Home
- SNX vs ICLR Comparison
SNX vs ICLR Comparison
Compare SNX & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNX | ICLR |
|---|---|---|
| Founded | 1980 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 15.1B |
| IPO Year | 2003 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SNX | ICLR |
|---|---|---|
| Price | $152.02 | $200.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $168.60 | ★ $202.38 |
| AVG Volume (30 Days) | ★ 808.8K | 770.5K |
| Earning Date | 01-08-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | ★ 18.98 | N/A |
| EPS | ★ 9.21 | 7.47 |
| Revenue | ★ $60,973,509,000.00 | $8,102,602,000.00 |
| Revenue This Year | $7.25 | N/A |
| Revenue Next Year | $4.35 | $0.66 |
| P/E Ratio | ★ $16.53 | $26.96 |
| Revenue Growth | ★ 6.94 | N/A |
| 52 Week Low | $92.23 | $125.10 |
| 52 Week High | $167.76 | $228.29 |
Technical Indicators
Market Signals| Indicator | SNX | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 49.38 | 71.11 |
| Support Level | $149.96 | $180.48 |
| Resistance Level | $157.14 | $184.93 |
| Average True Range (ATR) | 2.90 | 5.59 |
| MACD | -0.09 | 1.52 |
| Stochastic Oscillator | 50.37 | 96.33 |
Price Performance
Historical ComparisonAbout SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.